Pfizer recalls Dopamine HCl Inj., USP, 200 mg/5 mL
FDAHome & Health recallNo official product photo was published for this recall.
What should I do?
Check your medicine against the product and lot details below. If it matches, stop using it, contact your pharmacist or doctor, and return it as directed.
What's the hazard?
Lack of Assurance of Sterility
What's affected
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.
More Home & Health recalls
High riskCostway Recalls Convertible High Chairs Due to Risk of Serious Injury or Death from Entrapment and Fall Hazards; Violate Mandatory Standard for High Chairs
Medium riskLithonia Lighting Recalls RSX Luminaires with Adjustable Tilt Arm Mountings Due to Risk of Serious Injury from Impact Hazard
High riskVQQQ Gas Patio Heaters Recalled Due to Risk of Serious Injury or Death from Fire and Burn Hazards